Connect with us

MB Stories

Innovation–The game changer for anesthesia machines

The market is growing significantly, allowing for quicker deployment in the healthcare sector, thanks to rising investments supporting anesthesia monitor technological advancements.

Technology for monitoring has significantly improved as a result of recent advancements in anesthesia-related equipment. It has been possible to save lives, thanks to the availability of video laryngoscopes, extubation catheters, cutting-edge supraglottic airway devices, and airway algorithms. Bedside ultrasonography, bispectral index monitoring, and sophisticated neuromuscular transmission monitoring systems are examples of perioperative technology advancements. A smartphone or tablet can now be used to connect to ultrasound machines for bedside echocardiography, regional anesthesia, or central line placement. In trying times, these developments have shown to be game changers.

The use of computer-controlled anesthesia machines is an emerging trend in the anesthesia machines market. Computer-controlled anesthesia machines help in reducing the patient’s pain during surgical procedures and also provide features, such as alarms to notify in case of an emergency or backup required to switch a defected pipeline or cylinder.

The integration of various functionalities, such as oxygen saturation level, carbon dioxide level, heart rate, and blood pressure, coupled with decision support systems and data analysis to aid clinicians to get better insights on their patients, is favoring the market growth. The introduction of new monitoring techniques, such as monitoring the depth of anesthesia, goal-directed fluid therapy, advanced neurological monitoring, improved alarm system, and technological advancements in objective pain assessment, is driving innovation in the industry. Decision support system (DSS) is another specialty of anesthesia. It is a digitized information receiver and relay center, which, in conjunction with anesthesia information management system (AIMS), helps the clinician in the delivery of health services, simultaneously monitoring the well-being of the patient. Thus, increasing investments, which are supporting the technological advancements in anesthesia monitors, are having a major impact on the market’s growth, enabling faster deployment in the healthcare industry.

The Indian anesthesia equipment market in 9M 2021 (January–September) is estimated at ₹172.87 crore, in comparison to ₹129.7 crore in 9M 2020. The market in 2021 seems to have moved in favor of the value segment, which while having seen an increased demand, also gained share from both the premium and performance models. This is in strong contrast to 2019, when the performance segment dominated with a 50-percent share. The prices have remained relatively stable.

In the 9M period in 2021, the government finalized orders against bids invited, but did not invite any fresh tenders. Orders were placed by the states; the Center, in line with the Make in India initiative, stayed away. For instance, AIIMS, New Delhi, did not finalize its orders, as indicated earlier. India saw many machines donated as part of the companies’ CSR activities, including from overseas companies, like Amazon.

Indian anesthesia equipment market

Major vendors*

Tier I

Tier II

Tier III

Others

GE Mindray BPL-Penlon and Drager Allied Medical (Meditec England), Skanray, Aeon Medical, local & regional brands
*Vendors are placed in different tiers on the basis of their sales contribution to the overall revenues of the Indian anesthesia equipment market.
ADI Media Research

In the 9M period in 2021, the government finalized orders against bids invited, but did not invite any fresh tenders. Orders were placed by the states; the Center, in line with the Make in India initiative, stayed away. For instance, AIIMS, New Delhi, did not finalize its orders, as indicated earlier. India saw many machines donated as part of the companies’ CSR activity, including from overseas companies, like Amazon.

The market since October 2021 is returning to normalcy. Corporate chains are inviting RFPs, and smaller hospitals are also exploring the market. However, the government has so far given no indication that it has any major expansion or procurement plans.

The Indian buyers are warming up to the high-flow nasal cannula (HFNC) oxygen machines being introduced by various brands. These high-end machines extend safe apneic time from 8 to up to 30 minutes to help clinicians intubate more easily, integrate automatic controlled anesthesia that automatically adjusts fresh gas and vaporizer output to quickly achieve pre-set target end-tidal agent and inspiratory oxygen concentration, and while reducing cost by minimizing the consumption of gas and agents used throughout the case, also cuts down on workload for clinicians.

The global anesthesia machines market is expected to grow from USD 9.44 billion in 2020 to USD 12.77 billion in 2021 at a compound annual growth rate (CAGR) of 35.3 percent. The growth is mainly due to use of anesthesia machines being converted to ventilators to support the patients affected by Covid-19, which has spiked the demand for the equipment. The anesthesia machines market is expected to reach USD 18.62 billion in 2025 at a CAGR of 9.9 percent.

The anesthesia machines segment accounted for the largest segment, accounting for more than 50 percent share of the total market in 2021, due to the increasing number of surgical procedures and rising awareness about preventive healthcare measures. However, the anesthesia disposables segment is expected to witness double-digit growth rate throughout the coming years. Among the anesthesia machines segment, anesthesia-delivery machines sub-segment held the largest revenue share, while anesthesia ventilators sub-segment is anticipated to register the fastest growth rate during 2021–2025.

Stringent government regulations and high installation costs are some of the factors that are expected to stymie market expansion to some extent. A key limitation for the anesthesia devices market is the risk of contamination, caused by the use of anesthetic machines during surgical procedures. This is mostly due to increase in the number of surgeries and use of anesthetic machines, which increases the risk of bacterial infections. Microorganisms frequently infect anesthesia devices. One example is the exterior section of an anesthetic machine, which includes bacteria that can be transported from the equipment to the anesthetist and then to the patient, causing bacterial contamination and illness. Creation of anesthetic systems is a time-consuming and complicated process, and lack of standards for their validation and repeatability is hindering anesthesia machinery market growth.

North America is expected to dominate the overall market over the next four years. In the North American region, the United States holds the largest market share, and this is due to the rapid increase in a number of diseases, such as obesity, cardiovascular problems, and different types of cancers, which have contributed to the rise in the number of surgeries of both open as well as minimally invasive types.

The anesthesia devices market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising patient awareness levels and high prevalence of diseases and a rising number of surgeries, a few other smaller players are expected to enter into the market in the coming years. Some of the major players of the market are GE Healthcare, Becton Dickinson and Company, Smiths Group plc., Ambu S/A, Teleflex Incorporated, Ventlab, Drägerwerk AG & Co. KGaA, SunMed, 3M Company, and Airsep Corporation. The other players operating in the industry include Koninklijke Philips NV, Aircraft Medical, Verathon Inc., Karl Storz GmbH & Co. KG, and Pentax.

The two main directions for anesthesia innovation in the future are automation and analytics. The equipment and delivery of drugs can be fully automated compared to manual distribution to gain a number of advantages. There is a lot of data generated by monitoring in the ICU and during anesthesia, but most of it is useless. It may be possible to use this data to generate fresh insights that will benefit healthcare through the use of cutting-edge analytical techniques. One option for using analytics in anesthesia and the ICU is personalized data use for repeat patients and precision medicine.

Copyright © 2024 Medical Buyer

error: Content is protected !!